Stryker price target raised to $63 from $59 at RW Baird

theflyonthewall.com

Baird raised its price target on Stryker following pre-announced Q4 results. The firm noted its solid organic growth in orthopedic implants and believes the company;s long term earnings growth targets remain achievable. Shares are Outperform rated.

View Comments (0)